LifeMD (LFMD) Asset Writedowns and Impairment (2016 - 2020)

LifeMD's (LFMD) quarterly Asset Writedowns and Impairment came in at $74530.0 in Q4 2020, up 1728.72% on a QoQ basis from -$4576.0 in Q3 2017.

LifeMD (LFMD) Asset Writedowns and Impairment (2016 - 2020) Analysis & Trends

LifeMD (LFMD) has 3 years of Asset Writedowns and Impairment data on file, last reported at $74530.0 in Q4 2020.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $74530.0 in Q4 2020, while the trailing twelve-month figure through Dec 2021 was $74530.0 (up 17.48% YoY) and the FY2024 annual result came in at $675669.0, up 25.66% from the prior year.
Asset Writedowns and Impairment grew to $74530.0 in Q4 2020, from -$4576.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $114694.0 in Q4 2016 to a low of -$38027.0 in Q1 2017.
A 3-year average of $28021.0 and a median of -$4576.0 in 2017 frame the typical range for Asset Writedowns and Impairment.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	LifeMD	160.97 Mn	123.85 Mn	2.85 Mn

Download Data